Literature DB >> 4796580

High prevalence of rheumatoid arthritis in Yakima Indians.

R P Beasley, R F Willkens, P H Bennett.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4796580     DOI： 10.1002/art.1780160607

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Prevalence of rheumatoid arthritis in Dublin, Ireland: a population based survey.

Authors:  D Power; M Codd; L Ivers; S Sant; M Barry
Journal:  Ir J Med Sci       Date:  1999 Jul-Sep       Impact factor: 1.568

2.  Rheumatoid arthritis in a population sample in the Gulf: clinical observations.

Authors:  H M al Attia; O B Gatee; S George; M M Masri
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

Review 3.  Rheumatic disease in Native American children: opportunities and challenge.

Authors:  James N Jarvis; Sophia Y Cleland
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

Review 4.  Risk for rheumatic disease in relation to ethnicity and admixture.

Authors:  M Molokhia; P McKeigue
Journal:  Arthritis Res       Date:  2000-02-24

Review 5.  Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand.

Authors:  Kelle Hurd; Cheryl Barnabe
Journal:  Rheumatol Int       Date:  2016-12-17       Impact factor: 2.631

6.  Urinary Metals Concentrations and Biomarkers of Autoimmunity among Navajo and Nicaraguan Men.

Authors:  Madeleine K Scammell; Caryn Sennett; Rebecca L Laws; Robert L Rubin; Daniel R Brooks; Juan José Amador; Damaris López-Pilarte; Oriana Ramirez-Rubio; David J Friedman; Michael D McClean; Navajo Birth Cohort Study Team; Johnnye Lewis; Esther Erdei
Journal:  Int J Environ Res Public Health       Date:  2020-07-22       Impact factor: 3.390

7.  Chronic arthritis in children and adolescents in two Indian health service user populations.

Authors:  Joyce Mauldin; H Dan Cameron; Diane Jeanotte; Glenn Solomon; James N Jarvis
Journal:  BMC Musculoskelet Disord       Date:  2004-08-27       Impact factor: 2.362
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.